| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/03/2003 | WO2003000156A1 Zero-order prolonged release coaxial implants |
| 01/03/2003 | WO2003000143A1 Great saphenous vein varix treatment tool |
| 01/03/2003 | WO2003000075A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/03/2003 | WO2003000068A1 Improved hard sugar coating method |
| 01/03/2003 | WO2003000066A1 Chewing gum to control malodorous breath |
| 01/03/2003 | WO2003000065A2 Tooth whitening chewing gum |
| 01/03/2003 | WO2003000057A1 Solvent system |
| 01/03/2003 | WO2003000056A1 Joint lubrication with p2y purinergic receptor agonists |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2003000006A2 Stackable low depth tray |
| 01/03/2003 | WO2002092339A9 Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications |
| 01/03/2003 | WO2002092142A3 Polymeric corneal bandages/lenses for delivery of a pharmaceutical |
| 01/03/2003 | WO2002087596A3 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 01/03/2003 | WO2002080915A3 Composition for the treatment of night sight problems (halos, coma and glare) comprising aceclidine |
| 01/03/2003 | WO2002080885B1 Detoxification and decontamination using nanotechnology therapy |
| 01/03/2003 | WO2002080840A3 Immunity adjuvant containing a complexed metal cation and vaccine containing same |
| 01/03/2003 | WO2002074247A8 Pharmaceutical formulations for sustained release |
| 01/03/2003 | WO2002070594A3 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 01/03/2003 | WO2002066489A3 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 01/03/2003 | WO2002060869A3 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 01/03/2003 | WO2002056915A3 Complex of modafinil and cyclodextrin |
| 01/03/2003 | WO2002045754A3 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 01/03/2003 | WO2002045700A3 Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system |
| 01/03/2003 | WO2002030399A3 Polymer controlled delivery of a therapeutic agent |
| 01/03/2003 | WO2002026263A3 Stable solid dosage forms of amino acids and processes for producing same |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002005842A3 Preventing airway mucus production by administration of egf-r antagonists |
| 01/03/2003 | WO2002002086A1 Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloranilino)-phenyl!-ethanoic acid |
| 01/03/2003 | WO2002000193A3 Multiple stimulus reversible hydrogels |
| 01/03/2003 | WO2001086756A9 Coaxial connector having detachable locking sleeve |
| 01/03/2003 | WO2001068745A9 Liquid crystalline polymers |
| 01/03/2003 | WO2001066498A3 Method for obtaining a purified hydrofluoroalkane, purified hydrofluoroalkane, use of same and method for analysing same |
| 01/03/2003 | CA2714072A1 Nasal devices comprising a mouthpiece unit through which a subject exhales and a nosepiece including an inflatable cuff member |
| 01/03/2003 | CA2455288A1 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | CA2452088A1 Compositions and methods for intracellular delivery |
| 01/03/2003 | CA2451839A1 Pharmaceutical compositions comprising peptides and permeation enhancers |
| 01/03/2003 | CA2451434A1 Method and device for producing compression coated tablets |
| 01/03/2003 | CA2451432A1 Particles with improved solubilization capacity |
| 01/03/2003 | CA2451383A1 Regioselectively reticulated polysaccharides |
| 01/03/2003 | CA2451248A1 Composition comprising glycosaminoglycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 01/03/2003 | CA2451245A1 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 01/03/2003 | CA2451185A1 Spherical protein particles and methods of making and using them |
| 01/03/2003 | CA2451161A1 Method for high through put screening using a small scale mill or microfluidics |
| 01/03/2003 | CA2451152A1 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 01/03/2003 | CA2451148A1 Delivery of small hydrophilic molecules packaged into lipid vesicles |
| 01/03/2003 | CA2451146A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/03/2003 | CA2451091A1 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | CA2450957A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 01/03/2003 | CA2450762A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | CA2450758A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | CA2450748A1 Pharmaceutical compositions containing polymer and drug assemblies |
| 01/03/2003 | CA2450492A1 Nasal devices comprising a mouthpiece unit through which a subject exhales and a nosepiece including an inflatable cuff member |
| 01/03/2003 | CA2450480A1 Oxytocin agonists |
| 01/03/2003 | CA2450449A1 Pharmaceutical formulation |
| 01/03/2003 | CA2450001A1 Stable pharmaceutical compositions containing pravastatin |
| 01/03/2003 | CA2449998A1 Stable controlled release pharmaceutical compositions containing pravastatin |
| 01/03/2003 | CA2449439A1 Particles for inhalation having rapid release properties |
| 01/03/2003 | CA2422574A1 Appliance for large saphenous vein varix treatment |
| 01/02/2003 | US20030004449 Contains homogeneously distributed microcapsules of wound healing agents which are ruptured by external pressure or by dissolution in liquids exuded from the skin |
| 01/02/2003 | US20030004211 Carbohydrate modifying agent and drinks containing the modifying agent |
| 01/02/2003 | US20030004209 Anti-angiogenic compositions and methods of use |
| 01/02/2003 | US20030004206 Hypotensive agents; cardiovascular disorders |
| 01/02/2003 | US20030004205 Carvedilol-hydrophilic solutions |
| 01/02/2003 | US20030004182 Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency |
| 01/02/2003 | US20030004178 Synergistic mixture |
| 01/02/2003 | US20030004177 Abuse-resistant opioid dosage form |
| 01/02/2003 | US20030004155 Pharmaceutical compositions |
| 01/02/2003 | US20030004154 New crystal forms of oxcarbazepine and processes for their preparation |
| 01/02/2003 | US20030004143 In situ supplying; anticancer, antitumor agents |
| 01/02/2003 | US20030004135 Composition and method for the treatment of dysglucaemia |
| 01/02/2003 | US20030004133 Wound healing agents, antiulcer agents |
| 01/02/2003 | US20030004130 Homogeneous pharmaceutical compositions containing zidovudine and lamivudine |
| 01/02/2003 | US20030004118 Antibiotic/benzoyl peroxide dispenser |
| 01/02/2003 | US20030004100 Method of modifying the release profile of sustained release compositions |
| 01/02/2003 | US20030004096 Polypeptide mixture containing preservative, surfactant and stabilizer |
| 01/02/2003 | US20030004077 Environmentally desirable for use as refrigerants, aerosol propellants, metered dose inhalers, blowing agents for polymer foam, heat transfer media, and gaseous dielectrics |
| 01/02/2003 | US20030003584 Liposomal vector binding protein for hepatocyte DNA delivery |
| 01/02/2003 | US20030003511 Closure of bacterial ghost |
| 01/02/2003 | US20030003487 Mixed structures resulting from the incorporation of a biological macromolecule, especially of dna, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures |
| 01/02/2003 | US20030003229 Centrifuged rotating drum for treating cohesive powders |
| 01/02/2003 | US20030003170 Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
| 01/02/2003 | US20030003165 Hypertension-treatment composition containing panax notoginseng and salvia miltiorhiza and method of preparing same |
| 01/02/2003 | US20030003164 Use of dictyotal extracts in the production of a topical composition |
| 01/02/2003 | US20030003163 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 01/02/2003 | US20030003158 Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract |
| 01/02/2003 | US20030003156 Adjusting the degree of drying creates intial burst then linear release; drug delivery; may comprise risperidone within ethyl acetate/benzyl alcohol solvent blend |
| 01/02/2003 | US20030003155 Microprecipitation method for preparing submicron suspensions |
| 01/02/2003 | US20030003152 Over-coated product including tableted center and medicament |
| 01/02/2003 | US20030003151 Chemical delivery device |
| 01/02/2003 | US20030003150 System for osmotic delivery of pharmaceutically active agents |
| 01/02/2003 | US20030003149 Composition for pulsatile delivery of diltiazem and process of manufacture |
| 01/02/2003 | US20030003148 Comprises granulated rheology modifying polymers (modified acrylic acid-methacrylic acid homopolymers/copolymers) for making tablets by direct compression, without granulation first; bioavailability |
| 01/02/2003 | US20030003147 Effer-vescent bisphosphonate formulation |
| 01/02/2003 | US20030003146 Rapidly disintegrable pharmaceutical composition |
| 01/02/2003 | US20030003145 Comprises micronized N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3 -carboxamide |
| 01/02/2003 | US20030003144 Sustained release formulations for nifedipine, dextromethorphan, and danazol |
| 01/02/2003 | US20030003143 Lipidic microparticles linked to multiple proteins |
| 01/02/2003 | US20030003141 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited |
| 01/02/2003 | US20030003140 Absorbable solid compositions for topical treatment of oral mucosal disorders |
| 01/02/2003 | US20030003139 Transdermal system that contains a new highly potent gestagen |